Home / Products / Pharma / General / By Therapeutic Class / Antivertigo agent
Cinarzin (Cinnarizine) is a piperazine derivative with histamine H1 receptor and calcium-channel blocking activities. Cinarzin diminishes the main action of histamine in the body by competitive, reversible blockade of histamine receptor sites on tissue. It is indicated for the following reasons: Cerebral circulatory disorders: • Prophylaxis and maintenance therapy for symptoms of cerebral vascular spasm such as: dizziness, tinnitus, sleep rhythm disorder, depression, loss of memory etc. • Sequelae of cerebral and cranial trauma. • Postapoplectic disorders. • Migraine. Peripheral circulatory disorders: • Prophylaxis and maintenance therapy for symptoms of vascular spasm and arteriosclerosis such as: acrocyanosis, intermittent claudication, cold extremities, paresthesia, varicose ulcer, Raynaud's syndrome etc. Disorder of balance: • Prophylaxis and maintenance therapy for symptoms of labyrinthine, vestibular irritability, Meniere's syndrome such as: vertigo, dizziness, tinnitus, nystagmus, nausea, vomiting. • Prophylaxis of motion sickness. It is available as 15mg Tablet.
Cinnarizine BP + Dimenhydrinate BP
Cinarzin Plus contains two active ingredients Cinnarizine and Dimenhydrinate. The two substances belong to different groups of medicines. Cinnarizine is part of a group called calcium antagonists. Dimenhydrinate belongs to a group called antihistamines. Both substances work by reducing symptoms of vertigo (a feeling of dizziness or spinning) and nausea (feeling sick). The combination product is more effective than the individual compounds. Cinarzin Plus is used for the treatment of various kinds of nausea and vertigo. It is available as 10 x 10’s tablets in Alu-PVC blister strip.